Antony, France

Eric Parmantier



Average Co-Inventor Count = 7.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2015

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Eric Parmantier: Innovator in Medicinal Chemistry

Introduction

Eric Parmantier is a notable inventor based in Antony, France. He has made significant contributions to the field of medicinal chemistry, particularly in the development of novel compounds with potential therapeutic applications. His work focuses on creating innovative solutions to combat serious health issues, including cancer.

Latest Patents

Eric Parmantier holds a patent for "Pyrazolylbenzimidazole derivatives, compositions containing them and use thereof." This patent relates to compounds of formula (I), where R, R, R, R, and R are defined in the disclosure. The compounds are designed for use as medicaments, specifically as anticancer agents. The patent also details the process for preparing these compounds and the reaction intermediates involved.

Career Highlights

Eric Parmantier is currently employed at Aventis Pharma S.A., a leading pharmaceutical company. His role involves extensive research and development in the field of drug discovery. His innovative approach and dedication to advancing medicinal chemistry have positioned him as a valuable asset in the industry.

Collaborations

Throughout his career, Eric has collaborated with esteemed colleagues, including Marie-Pierre Cherrier and Hervé Minoux. These partnerships have fostered a collaborative environment that enhances the research and development process.

Conclusion

Eric Parmantier's contributions to medicinal chemistry, particularly through his patented innovations, highlight his commitment to improving healthcare solutions. His work continues to inspire advancements in the pharmaceutical industry.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…